These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2972258)

  • 1. [Clinical trial of 5'-DFUR in patients with recurrent breast cancer].
    Morimoto T; Komaki K; Yamakawa T; Tanaka T; Konishi Y; Uomine Y; Miki H; Ooshimo K; Monden Y
    Gan To Kagaku Ryoho; 1988 Oct; 15(10):2983-9. PubMed ID: 2972258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A comparative study of 5'-DFUR and tegafur in recurrent breast cancer].
    Taguchi T; Terasawa T; Abe O; Yoshida Y; Tominaga T; Ogawa N
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):2052-60. PubMed ID: 2932060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Usefulness of low dose 5'-DFUR (5'-deoxy-5-fluorouridine) for advanced or recurrent breast cancer].
    Sonoo H; Senoo T; Nishiki M; Morimoto T; Takashima S
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):951-8. PubMed ID: 10396323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical trial of 5'-deoxy-5-fluorouridine (5'-DFUR) in advanced cancer patients].
    Irie K; Yasutake K; Imamura Y; Yoshimura Y; Yoshida M; Nakamura T; Suehiro I
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2371-8. PubMed ID: 2934026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phase II study of 5'-DFUR in gastrointestinal and breast cancer].
    Tominaga T; Kitamura M; Hayashi K; Takahashi I; Kosaki G
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2172-8. PubMed ID: 2933000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of weekly paclitaxel and doxifluridine (5'-DFUR) combination therapy in patients with advanced or recurrent breast cancer].
    Okamoto Y; Tominaga T; Okuyama N; Sawada T; Kou Y
    Gan To Kagaku Ryoho; 2003 May; 30(5):661-7. PubMed ID: 12795098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of long-term oral chemotherapy with 5'-deoxy-5-fluorouridine and cyclophosphamide for recurrent breast cancer.
    Iba T; Kidokoro A; Fukunaga M; Sugiyama K; Aihara N; Suda M
    Int J Clin Oncol; 2004 Oct; 9(5):383-7. PubMed ID: 15549589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Phase II study of 5'-DFUR (5'-deoxy-5-fluorouridine) by the Cooperative Study Group].
    Taguchi T; Sakai K; Terasawa T; Irie K; Okajima K; Yamamoto M; Kawahara T; Satomi T; Tomita K; Yamaguchi A
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2179-84. PubMed ID: 2933001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phase II study of 5'-deoxy-5-fluorouridine (5'-DFUR) in patients with malignant cancer--a multi-institutional cooperative study].
    Niitani H; Kimura K; Saito T; Nakao I; Abe O; Urushizaki I; Ohta K; Yoshida Y; Kimura T; Kurihara M
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):2044-51. PubMed ID: 2932059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical trial of 5'-DFUR against various malignant tumors].
    Okumura T
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2365-70. PubMed ID: 2934025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Combination therapy of doxifluridine (5'-DFUR) + cyclophosphamide (CPA) + tamoxifen (TAM) for advanced or recurrent breast cancer. Joint Research Group in the Osaka Area for Combination Therapy of 5'-DFUR with Other Drugs].
    Ota J; Taguchi T; Sakai K; Irie K; Terasawa T; Shimoyama T; Kawahara T; Okumura T; Yamamoto M; Yasutake K
    Gan To Kagaku Ryoho; 1992 Aug; 19(9):1279-84. PubMed ID: 1386974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical trial of a new fluorinated pyrimidine, 5'-deoxy-5-fluorouridine (5'-DFUR)].
    Hoshino A; Ohara K; Kamiya O; Nagata K; Ono Y; Kawakubo A; Ozaki Y; Suzuki A; Ogasawara T; Sugiura I
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):1079-82. PubMed ID: 2938548
    [No Abstract]   [Full Text] [Related]  

  • 13. [A phase I study of docetaxel (TXT) and doxifluridine (5'-DFUR) combination therapy in patients with advanced and recurrent breast cancer].
    Tominaga T; Nishimura R; Aoyama H; Iwase H; Mitsuyama S; Asaga T; Kimura M;
    Gan To Kagaku Ryoho; 2001 Jul; 28(7):965-72. PubMed ID: 11478146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phase II study of 5'-DFUR treatment of the bladder and prostatic cancer].
    Ohmori H; Matsumura Y; Ochi J; Kobashi K; Akebi N; Saika T; Nanba K; Tanahashi T; Josen T; Nasu Y
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2307-14. PubMed ID: 1834024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of DAC (doxifluridine, adriamycin, cyclophosphamide) chemotherapy in advanced breast cancer patients].
    Tashiro H; Takahashi I; Yamamura S; Ishikawa T; Yanaga K; Wakasugi K; Matsusaka T; Kume K
    Gan To Kagaku Ryoho; 1999 May; 26(6):775-9. PubMed ID: 10410146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combination therapy of high dose doxifluridine (5'-DFUR)+mitomycin C (MMC) for advanced or recurrent colorectal cancer. Joint Research Group in the Osaka Area for Combination Therapy of 5'-DFUR with Other Drugs].
    Kikkawa N; Taguchi T; Sakai K; Irie K; Terasawa T; Shimoyama T; Iwanaga T; Fukuda I; Okumura S; Yasutake K
    Gan To Kagaku Ryoho; 1993 Jan; 20(1):117-23. PubMed ID: 8422175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phase II study of 5'-DFUR in uterine cervical cancer and ovarian cancer].
    Noda K; Ikeda M; Saito Y; Yajima A; Sato A; Suzuki M; Terashima Y; Ochiai K; Yoshida K; Takada M
    Gan To Kagaku Ryoho; 1991 Dec; 18(15):2557-65. PubMed ID: 1660700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Phase II study of 5'-DFUR (Furtulon) capsule for bladder cancer].
    Kubota Y; Miura T; Shuin T; Kinoshita Y; Hosaka M; Kondo I; Moriyama M; Fukushima S; Fukuoka H; Miyai K
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2301-6. PubMed ID: 1834023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of CGS16949A in advanced or recurrent breast cancer--a multi-institutional late phase II clinical trial].
    Aoyama H; Asaishi K; Abe R; Kajiwara T; Enomoto K; Yoshida M; Ohasi Y; Tominaga T; Abe O
    Gan To Kagaku Ryoho; 1994 Mar; 21(4):477-84. PubMed ID: 8129388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A comparative study with 5'-DFUR alone or in combination with tamoxifen (TAM) or medroxyprogesterone acetate (MPA) for advanced or recurrent breast cancer].
    Takatsuka Y; Yayoi E; Miyauchi K; Aikawa T; Maeura Y; Hirai T; Kotsuma Y
    Gan To Kagaku Ryoho; 1992 May; 19(5):631-6. PubMed ID: 1533755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.